Polyester amine Composed of Polyethylenimine and Pluronic Enhance

Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro

Figure 1 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 2 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 3 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 4 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 5 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 6 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 7 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 8 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 9 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Slides: 10

Download presentation

Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro

Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice Mingxing Wang, Bo Wu, Jason D Tucker, Lauren E Bollinger, Peijuan Lu, Qilong Lu Molecular Therapy - Nucleic Acids Volume 5 (January 2016) DOI: 10. 1038/mtna. 2016. 51 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 1 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 2 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 3 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 4 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 5 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 6 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 7 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 8 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 8 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 9 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51)

Figure 9 Molecular Therapy - Nucleic Acids 2016 5 DOI: (10. 1038/mtna. 2016. 51) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions